rns now7 Sep 2020 15:37
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the statement made by BBI Solutions Limited earlier today regarding an order from the UK Government and successful independent evaluations in relation to the AbC-19™ test developed by the UK-RTC. This was released by BBI in error and contained incorrect information. The statement has been withdrawn by BBI and should be disregarded. Any future updates on potential UK Government orders or the outcome of independent evaluations will be disclosed to shareholders once these are concluded.